Oswald Jessica, Shahi Varun, Chakravarthy Krishnan V
Department of Anesthesiology & Pain Medicine, University of California San Diego Health Sciences, San Diego, CA 92037, USA.
Department of Emergency Medicine, University of California, Oakland, CA 90095, USA.
Pain Manag. 2019 Nov;9(6):551-558. doi: 10.2217/pmt-2019-0028. Epub 2019 Nov 5.
This case series looks at outcomes in 39 patients implanted using the Bioness Stimrouter system on various isolated mononeuropathies. A case series of 39 patients with a total of 42 implants were enrolled starting August 2017 at various pain management centers. Of 39 patients studied, 78% of the participants noticed an improvement in their pain. There was a 71% reduction in pain scores with the average preprocedure score of 8 improving to 2 post-implant. Participants noted on average a 72% improvement in activity with the greatest observed in the brachial plexus (80%) and suprascapular nerve (80%) and smallest in the intercostal nerve (40%). Approximately 89% of those implanted with a peripheral nerve stimulator experienced a greater than 50% reduction in opioid consumption. Peripheral nerve stimulators are a new, minimally invasive neuromodulation modality that shows promising early results in our 39-patient case series.
本病例系列研究了39例使用Bioness Stimrouter系统植入治疗各种孤立性单神经病的患者的治疗效果。从2017年8月起，在各个疼痛管理中心招募了一个包含39例患者、共植入42个装置的病例系列。在研究的39例患者中，78%的参与者注意到疼痛有所改善。疼痛评分降低了71%，术前平均评分为8分，植入后改善至2分。参与者平均表示活动能力提高了72%，其中臂丛神经（80%）和肩胛上神经（80%）改善最为明显，肋间神经改善最小（40%）。植入外周神经刺激器的患者中，约89%的人阿片类药物消耗量减少了50%以上。外周神经刺激器是一种新型的微创神经调节方式，在我们这个39例患者的病例系列中显示出了令人鼓舞的早期效果。
